Subasumstat by Takeda Pharmaceutical for Relapsed Multiple Myeloma: Likelihood of Approval

Subasumstat is under clinical development by Takeda Pharmaceutical and currently in Phase II for Relapsed Multiple Myeloma.

High testosterone levels in older men associated with greater risk of atrial fibrillation

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males.

May 2, 2024

Serotonin 2C receptor in the brain regulates memory in people and animal models, research shows

Researchers at Baylor College of Medicine, the University of Cambridge in the U.K. and collaborating institutions have shown that serotonin 2C receptor in the brain

June 29, 2024

The prevalence of clustering of health behaviors and associated physical and mental health outcomes

Researchers conducted a systematic review of the literature investigating the associations between lifestyle, health behaviors, and health outcomes.

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.